104 related articles for article (PubMed ID: 17542668)
21. Lymphocytic infiltration in pediatric thyroid carcinomas.
Van Savell H; Hughes SM; Bower C; Parham DM
Pediatr Dev Pathol; 2004; 7(5):487-92. PubMed ID: 15547772
[TBL] [Abstract][Full Text] [Related]
22. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
[TBL] [Abstract][Full Text] [Related]
23. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
[TBL] [Abstract][Full Text] [Related]
24. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
[TBL] [Abstract][Full Text] [Related]
26. Cell size as a prognostic factor in oncocytic poorly differentiated carcinomas of the thyroid.
Asioli S; Righi A; Volante M; Chiusa L; Lloyd RV; Bussolati G
Hum Pathol; 2014 Jul; 45(7):1489-95. PubMed ID: 24745614
[TBL] [Abstract][Full Text] [Related]
27. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
28. Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.
Coventry BJ; Austyn JM; Chryssidis S; Hankins D; Harris A
Adv Exp Med Biol; 1997; 417():571-7. PubMed ID: 9286420
[TBL] [Abstract][Full Text] [Related]
29. Infiltrating papillary thyroid carcinoma: review of 134 cases of papillary carcinoma.
Mai KT; Perkins DG; Yazdi HM; Commons AS; Thomas J; Meban S
Arch Pathol Lab Med; 1998 Feb; 122(2):166-71. PubMed ID: 9499361
[TBL] [Abstract][Full Text] [Related]
30. Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer.
Eisenthal A; Polyvkin N; Bramante-Schreiber L; Misonznik F; Hassner A; Lifschitz-Mercer B
Hum Pathol; 2001 Aug; 32(8):803-7. PubMed ID: 11521223
[TBL] [Abstract][Full Text] [Related]
31. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
[TBL] [Abstract][Full Text] [Related]
32. High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma.
Park MH; Lee JS; Yoon JH
J Surg Oncol; 2012 Sep; 106(4):386-92. PubMed ID: 22422195
[TBL] [Abstract][Full Text] [Related]
33. [Undifferentiated carcinomas of the thyroid corpus. Apropos of 10 cases].
Habib K; Auriol M; Sarfati E; de Roquancourt A; Wann AR; Brocheriou C; Chomette G
Arch Anat Cytol Pathol; 1993; 41(3-4):129-39. PubMed ID: 8279854
[TBL] [Abstract][Full Text] [Related]
34. Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents.
Shah R; Banks K; Patel A; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4391-7. PubMed ID: 12213904
[TBL] [Abstract][Full Text] [Related]
35. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Am J Clin Pathol; 1988 Mar; 89(3):295-300. PubMed ID: 3348166
[TBL] [Abstract][Full Text] [Related]
36. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer.
Fiumara A; Belfiore A; Russo G; Salomone E; Santonocito GM; Ippolito O; Vigneri R; Gangemi P
J Clin Endocrinol Metab; 1997 May; 82(5):1615-20. PubMed ID: 9141559
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity.
Kikuchi K; Kusama K; Sano M; Nakanishi Y; Ishige T; Ohni S; Oinuma T; Nemoto N
Anticancer Res; 2006; 26(3A):1833-48. PubMed ID: 16827115
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic study of thyroid carcinoma infiltrating the trachea].
Tsumori T; Nakao K; Miyata M; Izukura M; Morita M; Kawashima Y; Sakurai M
Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):404-10. PubMed ID: 4000098
[TBL] [Abstract][Full Text] [Related]
39. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
40. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.
Volante M; Rapa I; Gandhi M; Bussolati G; Giachino D; Papotti M; Nikiforov YE
J Clin Endocrinol Metab; 2009 Dec; 94(12):4735-41. PubMed ID: 19837916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
